## Abstract We studied 48 patients after bilateral subthalamic nucleus deep brain stimulation (STN‐DBS) who were evaluated 6 months after the surgical procedure using the Unified Parkinson's Disease Rating Scale (UPDRS) in a standardized levodopa test. Additional follow‐up was available in 32 patie
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease
✍ Scribed by Jan Herzog; Jens Volkmann; Paul Krack; Florian Kopper; Monika Pötter; Delia Lorenz; Meike Steinbach; Stefan Klebe; Wolfgang Hamel; Bettina Schrader; Dieter Weinert; Dieter Müller; Hubertus M. Mehdorn; Günther Deuschl
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 74 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Although bilateral subthalamic deep brain stimulation (STN DBS) provides greater relief from the symptoms of Parkinson's disease (PD) than unilateral STN DBS, it has been suggested that unilateral STN DBS may be a reasonable treatment option in selected patients, especially those with h
## Abstract Eight patients with advanced PD received a unilateral STN DBS. The UPDRS III __off__ drug–on DBS was improved by a mean 44%. Dyskinesias were ameliorated. Levodopa daily dose was reduced. Three patients required the implantation of the second electrode__.__ Unilateral DBS may be efficac
## Abstract ## Background: Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silv
## Abstract Deep brain stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson's disease. The benefits of bilateral subthalamic stimulation are well documented, and some studies reported outcomes with a follow‐up of 5 to 6 years; nevertheless, few data are available
## Abstract Relatively little is known about the role of the basal ganglia in human deglutition. Deep brain stimulation (DBS) affords us a model for examining deglutition in humans with known impairment of the basal ganglia. The purpose of this study was to examine the effects of subthalamic nuclei